Abstract
Background: The purpose of this study was to evaluate the tumor biology with respect to bilaterality and recurrence rates for bilateral infiltrating lobular (IL) breast carcinoma in comparison with other histological types.
Methods: A prospectively accrued data base containing 1,548 breast cancer cases as well as H. Lee Moffitt Cancer Center's cancer registry compiled during the same period were queried for specific features relating to bilaterality and recurrence. The 116 patients in this study had been treated at the Comprehensive Breast Cancer Clinic and had documented bilateral breast cancer (invasive in situ).
Results: Eighty-two of the patients (70.7%) had metachronous breast cancer, and 34 (29.3%) had synchronous cancer. Although median follow-up times were short, the risk of developing breast cancer in the contralateral breast after the diagnosis of cancer in the ipsilateral breast was estimated to be 0.7% per patient-year of follow-up. Recurrence rates for IL cancers were compared with those for invasive ductal (ID) and for ID + IL cancers. IL cancers recurred 8.1% of the time, whereas ID cancers recurred at a rate of 7.8%. Recurrences were equally divided between local and distant sites.
Conclusions: Although IL cancers have demonstrated insidious behavior, their incidence of bilaterality is only slightly higher than other histologies and their rates of recurrence are low when properly evaluated and treated. The risk to the opposite breast also appears to be low. These data do not support the routine use of blind contralateral biopsy or prophylactic mastectomy.
Similar content being viewed by others
References
Pierson KK, Wilkinson EJ. Malignant neoplasia of the breast. In: Bland KI, Copeland EM, eds.The breast. Comprehensive management of benign and malignant diseases. Philadelphia: WB Saunders, 1991:193–209.
Yeatman TJ, Cantor AB, Smith TJ, et al. The tumor biology of infiltrating lobular carcinoma: implications for management.Ann Surg 1995;222:549–61.
Lee JS, Grant CS, Donohue JH, et al. Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer.Surgery 1985;118:640–7.
Ashikari R, Huvos AG, Urban JA, et al. Infiltrating lobular carcinoma of the breast.Cancer 1973;31:110–6.
Donegan WL, Perez-Mesa CM. Lobular carcinoma. An indication for elective biopsy of the second breast.Ann Surg 1972;176:178–87.
Anderson LI, Muchardto O. Simultaneous bilateral cancer of the breast—evaluation of the use of a contralateral biopsy.Acta Chir Scand 1980;146:407–9.
Wilson ND, Alberty RE. Bilateral carcinoma of the breast.Am J Surg 1973;126:244–8.
Newman W. Lobular carcinoma of the female breast.Ann Surg 1966;164:305–14.
Benfield JR, Fingerhut AC, Warner NE. Lobular carcinoma of the breast.Arch Surg 1969;99:129–31.
Warner NE. Lobular carcinoma of the breast.Cancer 1969;23:840–6.
Baker RR, Kuhajda FP. The clinical management of a normal contralateral breast in patients with lobular breast cancer.Ann Surg 1989;210:444–8.
Rosen PP, Braun DW Jr, Lyngholm B, et al. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy.Cancer 1981;47:813–9.
Wanebo HJ, Senofsky GM, Fechner RE, et al. Bilateral breast cancer. Risk reduction by contralateral biopsy.Ann Surg 1985;201:667–77.
Robbins GF, Berg JW. Bilateral primary breast cancer. A prospective clinicopathological study.Cancer 1961;17:1501–27.
Adair F, Berg J, Joubert L, et al. Long-term follow-up of breast cancer patients: the 30 year report.Cancer 1974;33:1145–50.
Burns PE, Dabbs K, May C, et al. Bilateral breast cancer in Northern Alberta: risk factors and survival patterns.Can Med Assoc J 1984;130:881–6.
Prior P, Waterhouse JAH. The incidence of bilateral breast cancer. II. A proposed model for the analysis of coincidental tumors.Br J Cancer 1981;43:615–22.
Hoskins KF. Stopfer JE, Calzone KA., et al. Assessment and counseling for women with a family history of breast cancer.JAMA 1995;273:577–85.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yeatman, T.J., Lyman, G.H., Smith, S.K. et al. Bilaterality and recurrence rates for lobular breast cancer: Considerations for treatment. Annals of Surgical Oncology 4, 198–202 (1997). https://doi.org/10.1007/BF02306610
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02306610